http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2247581-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-18 |
| filingDate | 2009-02-17^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5070e80287448225d580f3b31bd47b65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3699f5da516a31d1449c76fa188c082c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c485608534eca5d67ed1bdec00c781fb |
| publicationDate | 2010-11-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2247581-A2 |
| titleOfInvention | Cristallines, enantiomerically pure salt form of a betamimetic agent, and the use thereof as a medicament |
| abstract | The invention relates to a crystalline, enantiomerically pure hydrochloride salt of N-(5-{2-[3-(4,4-diethyl-2-oxo-4H-benzo[d][1,3]oxazin-1-yl)-1,1-dimethyl-propylamino]-1-hydroxy-ethyl}-2-hydroxy-phenyl)-methane sulfonamide, preferably N-(5-{(R)-2-[3-(4,4-diethyl-2-oxo-4H-benzo[d][1,3]oxazin-1-yl)-1,1-dimethyl-propylamino]-1-hydroxy- ethyl}-2-hydroxy-phenyl)-methane sulfonamide, and the effect thereof as a long-term betamimetic agent, alone or combined with at least one other active ingredient, in the treatment of respiratory diseases. |
| priorityDate | 2008-02-22^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 452 of 452.